Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT00569257
Eligibility Criteria:
Inclusion Criteria:
* LHRH receptor positive tumor status: positive receptor status determined by immunohistochemistry from primary tumor
* Histologically confirmed epithelial ovarian cancer (Stratum A)
* Advanced (FIGO III or IV) or recurrent disease
* Progression during treatment with a platinum-based regimen or within 6 months after receiving a platinum-based regimen
* Previous treatment with a taxane-containing regimen
* At least one measurable target lesion (RECIST criteria) OR CA125 level higher than twice the upper limit of normal range (GCIG criteria)
* Histologically confirmed endometrial cancer (Stratum B)
* Advanced (FIGO III or IV) or recurrent disease not amenable to potentially curative treatment with local surgery and/or radiation therapy
* No previous anthracycline-based chemotherapy
* At least one measurable target lesion according to RECIST criteria
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00569257
Study Brief:
Protocol Section:
NCT00569257